BIOMAT Database Logo BIOMAT Database Logo

Synthesis, molecular modelling, and antibacterial evaluation of new sulfonamide-dyes based pyrrole compounds. 2024

Hatem E Gaffer, and S A Mahmoud, and M S El-Sedik, and Tarek Aysha, and Mohamed H Abdel-Rhman, and Ehab Abdel-Latif
Dyeing, Printing, and Auxiliaries Department, National Research Centre, Textile Institute, Giza, Cairo, Egypt. hatemgaafar197@gmail.com.

In this study, we synthesized new series of 5-oxo-2-phenyl-4-(arylsulfamoyl)sulphenyl) hydrazono)-4,5-dihydro-1H-pyrrole-3-carboxylate hybrids 4a-f with the goal of overcoming sulfonamide resistance and identifying novel therapeutic candidates by chemical changes. The chemical structures of the synthesized hybrids were established over the spectroscopic tools. The frontier molecular orbitals configuration and energetic possessions of the synthesized compounds were discovered utilizing DFT/B3LYP/6-311++ G** procedure. The 3D plots of both HOMO and LUMO showed comparable configuration of both HOMO and LUMO led to close values of their energies. Amongst the prepared analogues, the sulfonamide hybrids 4a-f, hybrid 4a presented potent inhibitory towards S. typhimurium with (IZD = 15 mm, MIC = 19.24 µg/mL) and significant inhibition with (IZD = 19 mm, MIC = 11.31 µg/mL) against E.coli in contrast to sulfonamide (Sulfamethoxazole) reference Whereas, hybrid 4d demonstrated potent inhibition with (IZD = 16 mm, MIC = 19.24 µg/mL) against S. typhimurium with enhanced inhibition against E. Coli, Additionally, the generated sulfonamide analogues'' molecular docking was estimated over (PDB: 3TZF and 6CLV) proteins. Analogue 4e had the highest documented binding score as soon as linked to the other analogues. The docking consequences were fitting and addressed with the antibacterial valuation.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012486 Salmonella typhimurium A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER. Salmonella typhimurium LT2
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Hatem E Gaffer, and S A Mahmoud, and M S El-Sedik, and Tarek Aysha, and Mohamed H Abdel-Rhman, and Ehab Abdel-Latif
Synthesis of some novel coumarin isoxazol sulfonamide hybrid compounds, 3D-QSAR studies, and antibacterial evaluation.
October 2021, Scientific reports,
Hatem E Gaffer, and S A Mahmoud, and M S El-Sedik, and Tarek Aysha, and Mohamed H Abdel-Rhman, and Ehab Abdel-Latif
Synthesis and antibacterial evaluation of new, unsymmetrical triaryl bisamidine compounds.
August 2014, Bioorganic & medicinal chemistry letters,
Hatem E Gaffer, and S A Mahmoud, and M S El-Sedik, and Tarek Aysha, and Mohamed H Abdel-Rhman, and Ehab Abdel-Latif
Synthesis, identification, and antibacterial activity of new sulfonamide nanoparticles.
September 2012, IEEE transactions on nanobioscience,
Hatem E Gaffer, and S A Mahmoud, and M S El-Sedik, and Tarek Aysha, and Mohamed H Abdel-Rhman, and Ehab Abdel-Latif
Design, Synthesis and Antibacterial Evaluation of Compounds Based on New Benzoxepine-oxime-1,2,3-triazole Hybrid.
January 2018, Mini reviews in medicinal chemistry,
Hatem E Gaffer, and S A Mahmoud, and M S El-Sedik, and Tarek Aysha, and Mohamed H Abdel-Rhman, and Ehab Abdel-Latif
Development of Oxadiazole-Sulfonamide-Based Compounds as Potential Antibacterial Agents.
October 2021, ACS omega,
Hatem E Gaffer, and S A Mahmoud, and M S El-Sedik, and Tarek Aysha, and Mohamed H Abdel-Rhman, and Ehab Abdel-Latif
Synthesis, Application, and Antibacterial Activity of New Direct Dyes based on Chromene Derivatives.
August 2022, Current organic synthesis,
Hatem E Gaffer, and S A Mahmoud, and M S El-Sedik, and Tarek Aysha, and Mohamed H Abdel-Rhman, and Ehab Abdel-Latif
Molecular modeling, synthesis, antibacterial and cytotoxicity evaluation of sulfonamide derivatives of benzimidazole, indazole, benzothiazole and thiazole.
July 2018, Bioorganic & medicinal chemistry,
Hatem E Gaffer, and S A Mahmoud, and M S El-Sedik, and Tarek Aysha, and Mohamed H Abdel-Rhman, and Ehab Abdel-Latif
Molecular modelling and synthesis of quinazoline-based compounds as potential antiproliferative agents.
January 2014, Chemical & pharmaceutical bulletin,
Hatem E Gaffer, and S A Mahmoud, and M S El-Sedik, and Tarek Aysha, and Mohamed H Abdel-Rhman, and Ehab Abdel-Latif
Identification of sulfonamide compounds active on the insect nervous system: Molecular modeling, synthesis and biological evaluation.
January 2023, Bioorganic & medicinal chemistry letters,
Hatem E Gaffer, and S A Mahmoud, and M S El-Sedik, and Tarek Aysha, and Mohamed H Abdel-Rhman, and Ehab Abdel-Latif
Synthesis, biological evaluation and molecular docking of new sulfonamide-based indolinone derivatives as multitargeted kinase inhibitors against leukemia.
December 2021, Bioorganic chemistry,
Copied contents to your clipboard!